• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inmed Pharmaceuticals Inc (NQ: INM )

0.2605 -0.0054 (-2.03%)
Streaming Delayed Price Updated: 3:59 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inmed Pharmaceuticals Inc

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
InMed (NASDAQ: INM) Positioned to Offer Rare Cannabinoid Manufacturing Technologies
February 15, 2022
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) in Unique Position to Offer Full Slate of Rare Cannabinoid Manufacturing Technologies
February 14, 2022
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) in Unique Position to Offer Full Slate of Rare Cannabinoid Manufacturing Technologies
February 14, 2022
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
InMed Pharmaceuticals' Issues Annual Shareholder Letter
January 05, 2022
InMed Pharmaceuticals (NASDAQ: 
Via Benzinga
InMed Pharmaceuticals To Release Q2 Financial Report, Update
February 11, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. InMed Pharmaceuticals (NASDAQ: INM), a... 
Via Benzinga
InMed Pharmaceuticals (NASDAQ: INM) to Release Q2 Financial Report, Update
February 11, 2022
Via Investor Brand Network
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Release Q2 Financial Report, Business Update
February 10, 2022
Via Investor Brand Network
InMed Pharmaceuticals Strengthens Leading Role In Rare Cannabinoid Market
February 04, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Cannabicitran is the first of four new rare cannabinoids InMed... 
Via Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Strengthens Leading Role in Rare Cannabinoid Market
February 04, 2022
Via Investor Brand Network
InMed Pharmaceuticals Inc. (NASDAQ: INM) Strengthens Leading Role in Rare Cannabinoid Market Following New Product Launch, Key Acquisition
February 03, 2022
Via Investor Brand Network
InMed Pharmaceuticals Defining Value Of Rare Cannabinoids In Pharma Space
February 03, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Defining Value of Rare Cannabinoids in Pharma Space
February 03, 2022
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
CBDNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Blazing Trail in Defining Value of Rare Cannabinoids in Pharmaceutical Space
February 02, 2022
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
InMed (NASDAQ: INM) Gains Potential to Synthetically Produce Rare Cannabinoids at Scale
February 02, 2022
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Recent Access of Manufacturing Technologies Now Give It the Potential to Synthetically Produce Rare Cannabinoids at Large Scale, a Unique and Coveted Position in the Rapidly Developing Rare Cannabinoid Space
February 01, 2022
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
InMed Pharmaceuticals (NASDAQ: INM) Leveraging Growing Cannabinoid-Based Pharma Market
January 27, 2022
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging on the Growing Cannabinoid-Based Pharmaceuticals Market
January 26, 2022
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging on the Growing Cannabinoid-Based Pharmaceuticals Market
January 26, 2022
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
InMed Pharmaceuticals Expands Rare Cannabinoid Product Portfolio to Launch CBT
January 20, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. InMed Pharmaceuticals (NASDAQ: INM), a... 
Via Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Expands Rare Cannabinoid Product Portfolio to Launch CBT
January 20, 2022
Via Investor Brand Network
Topics Supply Chain
Exposures Supply Chain
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Rare Cannabinoid Product Portfolio to Launch CBT
January 19, 2022
Via Investor Brand Network
Topics Supply Chain
Exposures Supply Chain
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Rare Cannabinoid Product Portfolio to Launch CBT
January 19, 2022
Via CannabisNewsWire
Topics Supply Chain
Exposures Supply Chain
4 Penny Stocks Insiders Are Buying
January 07, 2022
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste... 
Via Benzinga
InMed Pharmaceuticals’ (NASDAQ: INM) Issues Annual Shareholder Letter
January 05, 2022
Via Investor Brand Network
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Annual Shareholder Letter Provides Company Highlights, 2022 Outlook
January 05, 2022
Via Investor Brand Network
InMed Pharmaceuticals to Present at Tribe Public's Webinar Event
December 30, 2021
InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing, and commercialization of rare cannabinoids, today announced that its CEO Eric A. Adams, SVP and... 
Via Benzinga
InMed Pharmaceuticals (NASDAQ: INM) to Present at Tribe Public’s Webinar Event
December 30, 2021
Via Investor Brand Network
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at Tribe Public’s Webinar Event
December 30, 2021
Via Investor Brand Network
InMed Pharmaceuticals Announces Publication of Article on CBN as Possible Glaucoma Treatment
December 20, 2021
InMed Pharmaceuticals (NASDAQ: 
Via Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Announces Publication of Article on CBN as Possible Glaucoma Treatment
December 20, 2021
Via Investor Brand Network
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap